Levels of CRP, fibrinogen, Lp-PLA2 activity and PTX-3 were higher in subjects with MetS compared to those without MetS, while Lp-PLA2 mass levels were significantly lower in the former group. This evidence concerns the gene PTX3 and metabolic syndrome.